Other
T Cells
0
Pipeline Programs↗
25
Active Trials↗
4
Companies Involved↗
T Cells is an early-stage landscape with 0 programs across 4 companies. The most active players are Hrain Biotechnology Co., Ltd., CARsgen Therapeutics Co., Ltd., Bioceltech Therapeutics, Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
63
clinical trials
Recruiting15 · 24%
Completed14 · 22%
Unknown status12 · 19%
Terminated8 · 13%
Active, not recruiting7 · 11%
Withdrawn3 · 5%
Other4 · 6%
Clinical Trials
Trial Activity
63 trials
Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers
Recruiting·SSecond Affiliated Hospital of Guangzhou Medical University·Phase 1·NCT05779917·30 enrolled
CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL
Recruiting·—·Phase 1·NCT06445803·48 enrolled
Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells
Recruiting·—·Phase 4·NCT04957329·28 enrolled
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
Recruiting·—·Phase 1/2·NCT06839976·24 enrolled
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers
Recruiting·SSecond Affiliated Hospital of Guangzhou Medical University·Phase 1·NCT03198052·30 enrolled
Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects
Recruiting·—·Phase 2/3·NCT05653258·160 enrolled
GPC3/Mesothelin-CAR-γδT Cells Against Cancers
Recruiting·SSecond Affiliated Hospital of Guangzhou Medical University·Phase 1·NCT06196294·30 enrolled
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)